Fig. 8From: Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma AÂ Comparison of potential targeted drug sensitivities in high- and low-risk groups. Correlation between responses to some FDA-approved drugs and expression levels of TFRC (B) and SLC7A11 (C)Back to article page